Cel Sci (CVM) Other Accumulated Expenses (2010 - 2020)
Cel Sci (CVM) reported Other Accumulated Expenses of $5,000 for fiscal Q2 2020 (quarter ended Mar 31, 2020), down 64.2% from $13,984 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Cel Sci (CVM) Other Accumulated Expenses (2010 - 2020) Analysis & Trends
At the end of FY2019 (ended Sep 30, 2019), Cel Sci posted Other Accumulated Expenses of $14,956, up 6.6% from FY2018.
- Other Accumulated Expenses has increased for three consecutive fiscal years, though with a four-year compound annual growth rate of -5.8% (FY2015 to FY2019).
- By fiscal year, Other Accumulated Expenses came in at $14,029 in FY2018 (+12.7%), $12,449 in FY2017 (+276.1%), $3,310 in FY2016 (-82.6%) and $19,025 in FY2015.
- Five-year quarterly Other Accumulated Expenses spans a low of $3,310 in fiscal Q4 2016 and a high of $19,025 in fiscal Q4 2015.
- Year over year, Other Accumulated Expenses gained in five of the last eight quarters, with an average decline of 6.6%.
- The high point for year-over-year Other Accumulated Expenses in five years was fiscal Q4 2017 (growth of 276.1%); the low point was fiscal Q4 2016 (a decline of 82.6%).
- Per Business Quant data, the three fiscal quarters before Q2 2020 came in at $5,000 (Q1 2020), $14,956 (Q4 2019) and $16,009 (Q3 2019).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Cel Sci | 58.11 Mn | 32.46 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2020 | 5,000.00 |
| Dec 31, 2019 | 5,000.00 |
| Sep 30, 2019 | 14,956.00 |
| Jun 30, 2019 | 16,009.00 |
| Mar 31, 2019 | 13,984.00 |
| Dec 31, 2018 | 13,769.00 |
| Sep 30, 2018 | 14,029.00 |
| Jun 30, 2018 | 14,290.00 |
| Mar 31, 2018 | 14,576.00 |
| Dec 31, 2017 | 11,815.00 |
| Sep 30, 2017 | 12,449.00 |
| Jun 30, 2017 | 10,871.00 |
| Mar 31, 2017 | 7,792.00 |
| Dec 31, 2016 | 7,203.00 |
| Sep 30, 2016 | 3,310.00 |
| Dec 31, 2015 | 1.10 Mn |
| Sep 30, 2015 | 19,025.00 |
| Jun 30, 2015 | 1.27 Mn |
| Mar 31, 2015 | 1.10 Mn |
| Dec 31, 2014 | 1.10 Mn |
API Access
Cel Sci Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=CVM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "CVM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=CVM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();